Sino Biological,Inc. (301047.SZ)

70.51 -0.10 (-0.14%) At close: 03:04PM CST

Sino Biological,Inc.

Building 9
Jing Dongbei Technology Park No.18 Kechuang 10th Street BDA
Beijing 100176
China
86 400 890 9989
https://www.sinobiological.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 953

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Liangzhi Xie Ph.D.	Founder, President & Chairman	N/A	N/A	1966
Mr. Zhang Jie Ph.D.	GM, MD & Director	N/A	N/A	1973
Mr. Zhou Yong	Production Director	N/A	N/A	1982

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, and other reagents that are used in the areas of cancer, cardiovascular biology, cell and developmental biology, epigenetics, immunology, neuroscience, signal transduction, and stem cells. The company also provides pre-clinical production technology services for monoclonal antibody drug candidates; and custom services, such as protein production, antibody development and production, biological assay, and protein expression services. It serves academic research institutions, biotech companies, and pharmaceutical companies. The company was founded in 2016 and is headquartered in Beijing, China.

Corporate Governance

Sino Biological,Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.